More than 4,500 Uzbek citizens vaccinated with Chinese ZF 2001 against coronavirus
On December 12, phase III clinical trials of the recombinant vaccine ZF 2001, manufactured by the Chinese company Anhui Zhifei Longcom Biopharmaceutical, began in Uzbekistan, the press service of the Ministry of Innovative Development reported.
Photo: Ministry of Innovative Development
The trial is expected to include volunteers over 18 years of age who do not suffer from chronic diseases. Volunteers will be vaccinated with three doses of ZF 2001 during the trial period.
As of January 23, the number of people who came for screening was 9,596. Of these, 4,281 volunteers received the first dose of the vaccine, 251 – the second dose.
According to the ministerial press service, before the start of the third phase of the trial, more than twenty family members of the Ministry of Innovative Development leadership were vaccinated with the first dose of the recombinant vaccine imported from China.
Related News
10:25 / 03.02.2026
Tashkent and Beijing expand regional cooperation in green development and agriculture
11:20 / 31.01.2026
Uzbekistan temporarily restricts mandarin and pineapple imports from China over quarantine pests
09:33 / 29.01.2026
Chinese company plans to invest $500M in construction of paper factory in Samarkand
14:48 / 15.01.2026